Cargando…

LANDMark: an ensemble approach to the supervised selection of biomarkers in high-throughput sequencing data

BACKGROUND: Identification of biomarkers, which are measurable characteristics of biological datasets, can be challenging. Although amplicon sequence variants (ASVs) can be considered potential biomarkers, identifying important ASVs in high-throughput sequencing datasets is challenging. Noise, algor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudar, Josip, Porter, Teresita M., Wright, Michael, Golding, G. Brian, Hajibabaei, Mehrdad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969335/
https://www.ncbi.nlm.nih.gov/pubmed/35361114
http://dx.doi.org/10.1186/s12859-022-04631-z
_version_ 1784679225430638592
author Rudar, Josip
Porter, Teresita M.
Wright, Michael
Golding, G. Brian
Hajibabaei, Mehrdad
author_facet Rudar, Josip
Porter, Teresita M.
Wright, Michael
Golding, G. Brian
Hajibabaei, Mehrdad
author_sort Rudar, Josip
collection PubMed
description BACKGROUND: Identification of biomarkers, which are measurable characteristics of biological datasets, can be challenging. Although amplicon sequence variants (ASVs) can be considered potential biomarkers, identifying important ASVs in high-throughput sequencing datasets is challenging. Noise, algorithmic failures to account for specific distributional properties, and feature interactions can complicate the discovery of ASV biomarkers. In addition, these issues can impact the replicability of various models and elevate false-discovery rates. Contemporary machine learning approaches can be leveraged to address these issues. Ensembles of decision trees are particularly effective at classifying the types of data commonly generated in high-throughput sequencing (HTS) studies due to their robustness when the number of features in the training data is orders of magnitude larger than the number of samples. In addition, when combined with appropriate model introspection algorithms, machine learning algorithms can also be used to discover and select potential biomarkers. However, the construction of these models could introduce various biases which potentially obfuscate feature discovery. RESULTS: We developed a decision tree ensemble, LANDMark, which uses oblique and non-linear cuts at each node. In synthetic and toy tests LANDMark consistently ranked as the best classifier and often outperformed the Random Forest classifier. When trained on the full metabarcoding dataset obtained from Canada’s Wood Buffalo National Park, LANDMark was able to create highly predictive models and achieved an overall balanced accuracy score of 0.96 ± 0.06. The use of recursive feature elimination did not impact LANDMark’s generalization performance and, when trained on data from the BE amplicon, it was able to outperform the Linear Support Vector Machine, Logistic Regression models, and Stochastic Gradient Descent models (p ≤ 0.05). Finally, LANDMark distinguishes itself due to its ability to learn smoother non-linear decision boundaries. CONCLUSIONS: Our work introduces LANDMark, a meta-classifier which blends the characteristics of several machine learning models into a decision tree and ensemble learning framework. To our knowledge, this is the first study to apply this type of ensemble approach to amplicon sequencing data and we have shown that analyzing these datasets using LANDMark can produce highly predictive and consistent models. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-04631-z.
format Online
Article
Text
id pubmed-8969335
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89693352022-04-01 LANDMark: an ensemble approach to the supervised selection of biomarkers in high-throughput sequencing data Rudar, Josip Porter, Teresita M. Wright, Michael Golding, G. Brian Hajibabaei, Mehrdad BMC Bioinformatics Research BACKGROUND: Identification of biomarkers, which are measurable characteristics of biological datasets, can be challenging. Although amplicon sequence variants (ASVs) can be considered potential biomarkers, identifying important ASVs in high-throughput sequencing datasets is challenging. Noise, algorithmic failures to account for specific distributional properties, and feature interactions can complicate the discovery of ASV biomarkers. In addition, these issues can impact the replicability of various models and elevate false-discovery rates. Contemporary machine learning approaches can be leveraged to address these issues. Ensembles of decision trees are particularly effective at classifying the types of data commonly generated in high-throughput sequencing (HTS) studies due to their robustness when the number of features in the training data is orders of magnitude larger than the number of samples. In addition, when combined with appropriate model introspection algorithms, machine learning algorithms can also be used to discover and select potential biomarkers. However, the construction of these models could introduce various biases which potentially obfuscate feature discovery. RESULTS: We developed a decision tree ensemble, LANDMark, which uses oblique and non-linear cuts at each node. In synthetic and toy tests LANDMark consistently ranked as the best classifier and often outperformed the Random Forest classifier. When trained on the full metabarcoding dataset obtained from Canada’s Wood Buffalo National Park, LANDMark was able to create highly predictive models and achieved an overall balanced accuracy score of 0.96 ± 0.06. The use of recursive feature elimination did not impact LANDMark’s generalization performance and, when trained on data from the BE amplicon, it was able to outperform the Linear Support Vector Machine, Logistic Regression models, and Stochastic Gradient Descent models (p ≤ 0.05). Finally, LANDMark distinguishes itself due to its ability to learn smoother non-linear decision boundaries. CONCLUSIONS: Our work introduces LANDMark, a meta-classifier which blends the characteristics of several machine learning models into a decision tree and ensemble learning framework. To our knowledge, this is the first study to apply this type of ensemble approach to amplicon sequencing data and we have shown that analyzing these datasets using LANDMark can produce highly predictive and consistent models. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-04631-z. BioMed Central 2022-03-31 /pmc/articles/PMC8969335/ /pubmed/35361114 http://dx.doi.org/10.1186/s12859-022-04631-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rudar, Josip
Porter, Teresita M.
Wright, Michael
Golding, G. Brian
Hajibabaei, Mehrdad
LANDMark: an ensemble approach to the supervised selection of biomarkers in high-throughput sequencing data
title LANDMark: an ensemble approach to the supervised selection of biomarkers in high-throughput sequencing data
title_full LANDMark: an ensemble approach to the supervised selection of biomarkers in high-throughput sequencing data
title_fullStr LANDMark: an ensemble approach to the supervised selection of biomarkers in high-throughput sequencing data
title_full_unstemmed LANDMark: an ensemble approach to the supervised selection of biomarkers in high-throughput sequencing data
title_short LANDMark: an ensemble approach to the supervised selection of biomarkers in high-throughput sequencing data
title_sort landmark: an ensemble approach to the supervised selection of biomarkers in high-throughput sequencing data
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969335/
https://www.ncbi.nlm.nih.gov/pubmed/35361114
http://dx.doi.org/10.1186/s12859-022-04631-z
work_keys_str_mv AT rudarjosip landmarkanensembleapproachtothesupervisedselectionofbiomarkersinhighthroughputsequencingdata
AT porterteresitam landmarkanensembleapproachtothesupervisedselectionofbiomarkersinhighthroughputsequencingdata
AT wrightmichael landmarkanensembleapproachtothesupervisedselectionofbiomarkersinhighthroughputsequencingdata
AT goldinggbrian landmarkanensembleapproachtothesupervisedselectionofbiomarkersinhighthroughputsequencingdata
AT hajibabaeimehrdad landmarkanensembleapproachtothesupervisedselectionofbiomarkersinhighthroughputsequencingdata